Tactile Systems Adds Growth Strategist Andrea Pearson to Board

Tactile Systems Technology ( (TCMD) ) has shared an announcement.

On March 4, 2026, Tactile Systems Technology, Inc. elected healthcare growth strategist Andrea A. Pearson to its board of directors and set the board size at nine, with her appointment and committee roles effective March 9, 2026. Pearson, who has held senior growth and marketing roles at Harbor Health, DispatchHealth, HealthGrades and MapQuest, joins the Compliance & Reimbursement and Nominating & Corporate Governance Committees and will receive a mix of restricted stock units and prorated cash retainers under the company’s standard non-employee director compensation program.

The appointment brings to Tactile Medical more than 25 years of experience in scaling healthcare organizations, including leading DispatchHealth’s expansion from two to over 50 U.S. markets and driving substantial revenue and audience growth at prior companies. Chairman Bill Burke said her expertise in growth, innovation and patient engagement is expected to support the company’s efforts to reinforce its leadership in lymphatic dysfunction and airway clearance, signaling a strategic emphasis on accelerating market expansion and strengthening governance for stakeholders.

The most recent analyst rating on (TCMD) stock is a Buy with a $31.00 price target. To see the full list of analyst forecasts on Tactile Systems Technology stock, see the TCMD Stock Forecast page.

Spark’s Take on TCMD Stock

According to Spark, TipRanks’ AI Analyst, TCMD is a Neutral.

The score is anchored by solid profitability trends and a de-risked balance sheet, plus constructive 2026 guidance. Offsetting these positives are the sharply weak cash-flow profile in the financial statements, a mixed/neutral technical picture, and a relatively high P/E with no dividend support; Medicare prior-authorization uncertainty is an additional near-term overhang.

To see Spark’s full report on TCMD stock, click here.

More about Tactile Systems Technology

Tactile Systems Technology, Inc., which does business as Tactile Medical, is a medical technology company that develops and markets at-home therapies for people with underserved chronic conditions, including lymphedema, lipedema, chronic venous insufficiency and chronic inflammatory lung disease. The company focuses on collaborating with clinicians to build clinical evidence, raise awareness, improve access to care and reduce healthcare costs while enhancing quality of life for tens of thousands of patients each year.

The company positions itself as a leader in at-home treatment for lymphatic dysfunction and airway clearance, targeting patients who require long-term management of chronic disorders outside traditional hospital settings. By integrating its technologies into care pathways and emphasizing patient self-care, Tactile Medical aims to strengthen its market leadership in these niches within the broader medical technology and chronic care management sectors.

Average Trading Volume: 367,405

Technical Sentiment Signal: Buy

Current Market Cap: $646.5M

For detailed information about TCMD stock, go to TipRanks’ Stock Analysis page.